REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/08/2025
Back to search
Official data from USPTO
SYNTA PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SYNTA PHARMACEUTICALS
ST13
US500000076977979Class
5
Filing
76977979
Registration
3125571
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
08/09/2025
Trademark type
Word
Nice classes
5
Filing date
01/12/2005
Registration date
08/08/2006
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/11/2015
Last transaction
08/09/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/15/2002
First use in commerce
07/15/2002
Drawing code
4
Owner type
03
Owner location
Lexington, MA
Examiner
SINGLETON, RUDY
Law office
L20
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Synta Pharmaceuticals Corp.
Representatives
ROBERTA JACOBS-MEADWAY Eckert Seamans Cherin & Mellott L.L.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
PHARMACEUTICAL PRODUCTSDRUGS FOR INFLAMMATORY DISEASES AND CANCER
Publications
History of USPTO decisions and trademark events.
31 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/02/2016
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/11/2015
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/11/2015
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/11/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/11/2015
E89R
TEAS SECTION 8 & 9 RECEIVED
08/12/2015
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/08/2015
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/26/2014
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
07/26/2012
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/26/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/26/2012
E815
TEAS SECTION 8 & 15 RECEIVED
07/13/2012
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/26/2008
R.PR
REGISTERED-PRINCIPAL REGISTER
08/08/2006
PUBO
PUBLISHED FOR OPPOSITION
05/16/2006
NPUB
NOTICE OF PUBLICATION
04/26/2006
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/24/2006
ALIE
ASSIGNED TO LIE
03/17/2006
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/16/2006
IUAA
USE AMENDMENT ACCEPTED
03/16/2006
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
03/16/2006
MNDA
NOTICE OF DIVIDED TRADEMARK APPLICATION MAILED
02/14/2006
DPCC
DIVISIONAL PROCESSING COMPLETE
02/10/2006
IUAF
USE AMENDMENT FILED
01/31/2006
DRRR
DIVISIONAL REQUEST RECEIVED
01/31/2006
PAPER RECEIVED
01/31/2006
CNRT
NON-FINAL ACTION MAILED
08/17/2005
CNRT
NON-FINAL ACTION WRITTEN
08/16/2005
DOCK
ASSIGNED TO EXAMINER
08/12/2005
NWAP
NEW APPLICATION ENTERED
01/26/2005
Continuous trademark protection
Get notified about every new filing that threatens SYNTA PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.